SOUTH SAN FRANCISCO, Calif., Sept. 28 /PRNewswire-FirstCall/ -- VaxGen,
Inc. (Pink Sheets: VXGN) announced today that Jack Anthony has resigned
from the company's Board of Directors as a result of accepting the CEO
position at Osprey Pharmaceuticals. The Osprey Board has required that Mr.
Anthony relinquish all corporate directorships in accepting this position.
Mr. Anthony's resignation is effective immediately.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO)
"On behalf of VaxGen's directors and officers, I want to thank Jack for
his service to the company and its stockholders, and for his many
contributions to our efforts in pursuit of a strategic transaction," said
James P. Panek, VaxGen's President and CEO. "Since his appointment to the
Board in May, Jack has lent his active and expert assistance in helping us
formulate and consider various strategic alternatives. We wish him the very
best, and know that he will be a tremendous asset to Osprey." VaxGen
continues to seek qualified independent director candidates who will
contribute to its efforts in pursuit of strategic alternatives.
About VaxGen
VaxGen is a biopharmaceutical company based in Brisbane, California.
For more information, please visit the company's web site at
http://www.vaxgen.com.
Note: This press release contains "forward-looking statements" within
the meaning of the federal securities laws. These forward-looking
statements include without limitation, statements regarding the anticipated
filing of the company's outstanding quarterly reports and its application
for listing of its common stock. These statements are subject to risks and
uncertainties that could cause actual results and events to differ
materially from those anticipated. Readers are cautioned not to place undue
reliance on these forward-looking statements that speak only as of the date
of this release. VaxGen undertakes no obligation to update publicly any
forward-looking statements to reflect new information, events, or
circumstances after the date of this release except as required by law.
SOURCE VaxGen, Inc.
 back to top
Related links:
http://www.vaxgen.com
Photo Notes:
NewsCom: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO
AP Archive: http://photoarchive.ap.org PRN Photo Desk
photodesk@prnewswire.com
CONTACT:
Matthew J. Pfeffer, CFO of VaxGen, Inc.,
+1-650-624-2477
|
